OTCM
ONNVF
Market cap51mUSD
Oct 17, Last price
1.10USD
Name
Onco-Innovations Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
Net income
-421k
L+179,666.67%
CFO
-6k
L+2,603.43%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on pioneering cancer research and developing oncology treatments. A significant offering in their portfolio is ONC010, a product specifically designed for use in cancer therapies. This enterprise was founded on September 16, 2021, and conducts its operations from its headquarters located in Calgary, Canada.
Key people
Thomas Oshaughnessy
Chief Executive Officer, Director · since 2024
Nico Mah
Chief Financial Officer, Corporate Secretary, Director · since 2024
Graydon Bensler
Director · since 2024
Jared Rushton
Director · since 2025
Richard Heinzl
Independent Director · since 2024
Maximilian Justus
Independent Director · since 2024
Zachary Stadnyk
Independent Director · since 2024
Legal address
SUITE 2300, BENTALL 5, 550 BURRARD STREET
Vancouver, BC V6C 2B5
CA
Vancouver, BC V6C 2B5
CA
Headquarters
1309 - 7th Street SW
Calgary, AB T2R 1A5
CA
Calgary, AB T2R 1A5
CA
Valuation
Title in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2024‑04 | 2023‑04 | |
| Income | ||
Revenues | ||
Cost of revenue | ||
Unusual Expense (Income) | ||
NOPBT | ||
NOPBT Margin | ||
Operating Taxes | ||
Tax Rate | ||
NOPAT | ||
Net income | ||
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | ||
BB yield | ||
| Debt | ||
Debt current | ||
Long-term debt | ||
Deferred revenue | ||
Other long-term liabilities | ||
Net debt | ||
| Cash flow | ||
Cash from operating activities | ||
CAPEX | ||
Cash from investing activities | ||
Cash from financing activities | ||
FCF | ||
| Balance | ||
Cash | ||
Long term investments | ||
Excess cash | ||
Stockholders' equity | ||
Invested Capital | ||
ROIC | ||
ROCE | ||
| EV | ||
Common stock shares outstanding | ||
Price | ||
Market cap | ||
EV | ||
EBITDA | ||
EV/EBITDA | ||
Interest | ||
Interest/NOPBT |